Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Tuberculosis: burning issues: multidrug resistance and HIV-coinfection.

Janbaz KH, Qadir MI, Ahmad B, Sarwar A, Yaqoob N, Masood MI.

Crit Rev Microbiol. 2012 Nov;38(4):267-75. doi: 10.3109/1040841X.2012.664539. Epub 2012 Mar 16. Review.

PMID:
22421086
2.

[Tuberculosis and HIV co-infection: a therapeutic challenge].

Charbonnier F, Calmy A, Janssens JP.

Rev Med Suisse. 2011 Nov 23;7(318):2295-6, 2298-300. Review. French.

PMID:
22400365
3.

HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.

Rajasekaran S, Chandrasekar C, Mahilmaran A, Kanakaraj K, Karthikeyan DS, Suriakumar J.

J Indian Med Assoc. 2009 May;107(5):281-2, 284-6.

PMID:
19886382
4.

HIV-associated tuberculosis: diagnostic and treatment challenges.

El-Sadr WM, Tsiouris SJ.

Semin Respir Crit Care Med. 2008 Oct;29(5):525-31. doi: 10.1055/s-0028-1085703. Epub 2008 Sep 22. Review.

PMID:
18810685
5.

Extensively drug-resistant tuberculosis: new strains, new challenges.

Banerjee R, Schecter GF, Flood J, Porco TC.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):713-24. doi: 10.1586/14787210.6.5.713. Review.

PMID:
18847407
6.

HIV infection and multidrug-resistant tuberculosis: the perfect storm.

Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. Review.

PMID:
17624830
7.

Drug susceptibility profile of Mycobacterium tuberculosis isolated from HIV infected and uninfected pulmonary tuberculosis patients in eastern India.

Chakraborty N, De C, Bhattacharyya S, Mukherjee A, Santra S, Banerjee D, Sarkar RN, Guha SK.

Trans R Soc Trop Med Hyg. 2010 Mar;104(3):195-201. doi: 10.1016/j.trstmh.2009.09.004. Epub 2009 Oct 13.

PMID:
19828165
8.

Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?

Loeliger A, Suthar AB, Ripin D, Glaziou P, O'Brien M, Renaud-Thery F, Crowley S, Williams B, Ridzon R, Granich R, Gilks C.

Int J Tuberc Lung Dis. 2012 Jan;16(1):6-15. doi: 10.5588/ijtld.10.0626. Epub 2011 Aug 3. Review.

PMID:
21819645
9.

Drug resistance characteristics of Mycobacterium tuberculosis isolates to four first-line antituberculous drugs from tuberculosis patients with AIDS in Beijing, China.

Gao GJ, Lian L, Sun Y, Wei J, Xiao J, Wang X, Zhang L, Zhao X, Yang D, Zhao HX, Zhao H, Wang HZ, Wan KL, Li XW.

Int J Antimicrob Agents. 2015 Feb;45(2):124-9. doi: 10.1016/j.ijantimicag.2014.09.013. Epub 2014 Oct 22.

PMID:
25459740
10.

Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis.

March F, Garriga X, Rodríguez P, Moreno C, Garrigó M, Coll P, Prats G.

Clin Infect Dis. 1997 Nov;25(5):1044-7.

PMID:
9402354
11.

Modeling HIV/AIDS and tuberculosis coinfection.

Bhunu CP, Garira W, Mukandavire Z.

Bull Math Biol. 2009 Oct;71(7):1745-80. doi: 10.1007/s11538-009-9423-9. Epub 2009 May 28.

PMID:
19475456
12.

Diagnosis and management of TB in children: an update.

Marquez L, Starke JR.

Expert Rev Anti Infect Ther. 2011 Dec;9(12):1157-68. doi: 10.1586/eri.11.144. Review.

PMID:
22114966
13.

Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.

Joloba ML, Whalen CC, Cave DM, Eisenach KD, Johnson JL, Okwera A, Morrissey A, Bajaksouzian S, Feagin J, Mugerwa R, Ellner J, Jacobs MR.

East Afr Med J. 2000 Feb;77(2):111-5.

PMID:
10774085
14.

[Pericarditis due to multidrug resistant Mycobacterium tuberculosis in an HIV infected patient: case report and review of literature].

Lasso B M, Pérez G J.

Rev Chilena Infectol. 2009 Apr;26(2):156-61. doi: /S0716-10182009000200008. Epub 2009 Jun 16. Review. Spanish. Erratum in: Rev Chilena Infectol. 2009 Jun;26(3):280.

15.

Tuberculosis and HIV Coinfection.

Bruchfeld J, Correia-Neves M, Källenius G.

Cold Spring Harb Perspect Med. 2015 Feb 26;5(7):a017871. doi: 10.1101/cshperspect.a017871. Review.

16.

Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?

Di Perri G, Bonora S.

J Antimicrob Chemother. 2004 Sep;54(3):593-602. Epub 2004 Jul 28. Review.

PMID:
15282233
17.

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL.

AIDS. 2002 Jan 4;16(1):75-83.

PMID:
11741165
18.

[The specific features of the detection, clinical manifestations, and treatment of tuberculosis in the HIV-infected].

Erokhin VV, Kornilova ZKh, Alekseeva LP.

Probl Tuberk Bolezn Legk. 2005;(10):20-8. Russian.

PMID:
16318255
19.

First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran.

Tabarsi P, Chitsaz E, Moradi A, Baghaei P, Farnia P, Marjani M, Irannejad P, Mansouri D, Masjedi M.

Int J STD AIDS. 2009 Aug;20(8):566-70. doi: 10.1258/ijsa.2008.008379.

PMID:
19625590
20.

An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.

Chum HJ, O'Brien RJ, Chonde TM, Graf P, Rieder HL.

AIDS. 1996 Mar;10(3):299-309.

PMID:
8882670

Supplemental Content

Support Center